O

ONL Therapeutics

29 employees

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.

Basic info

Industry

biotechnology research

Sectors

Glaucoma
Biotechnology
Geographic Atrophy
Retinal Detachment
Health Care
Therapeutics
Pharmaceutical
Ophthalmic Drug Development

Date founded

2011

Funding rounds raised

Total raised

$47M

from 13 investors over 13 rounds

O

ONL Therapeutics raised $15M on March 8, 2023

Investors: Bios Partners, Visionary Venture Fund, 凯泰资本 and Michigan Capital Network

O

ONL Therapeutics raised $47M on December 22, 2020

Investors: InFocus Capital Partners, Bios Partners, 凯泰资本, Grand Angels and -

O

ONL Therapeutics raised $3M on August 22, 2019

Investors: InFocus Capital Partners and Invest Michigan

O

ONL Therapeutics raised $4.3M on May 17, 2017

Investors: -

O

ONL Therapeutics raised $1M on March 21, 2017

Investors: National Institutes of Health

FAQ